New Rx Inspector Tool helps consumers find critical safety information on generic drugs In a stunning revelation that strikes at the heart of public trust, a new investigative tool has ripped the veil off the U.S. Food and Drug Administration’s (FDA) long-standing practice of hiding critical safety data from the American people. While ninety percent of U.S. prescriptions are filled with generic drugs, many manufactured in overseas factories with documented histories of contamination and quality failures, the FDA has systematically kept this information shrouded in secrecy. Now, the Rx Inspector tool, developed by the Medill Investigative Lab and ProPublica…

Newswire

Features

The Latest